{"id":"W2046653378","doi":"10.3816/clc.2003.n.003","title":"Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario; Jewish General Hospital; McGill University; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Lung cancer; Adverse effect; Nausea; Internal medicine; Gastroenterology; Vomiting; Toxicity; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001508508,0.001699087,0.002295777,0.0004487729,0.000543681,0.001198864,0.001169462,0.001692784,0.004626551],"category_scores_gemma":[0.001151604,0.000641079,0.001179309,0.0004879073,0.001452952,0.0009904522,0.0003352967,0.004648056,0.0009631403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001074066,"about_ca_system_score_gemma":0.001401732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001559922,"about_ca_topic_score_gemma":0.002746829,"domain_scores_codex":[0.9995704,0.0002164176,0.00001596886,0.00006593581,0.00003231651,0.00009899215],"domain_scores_gemma":[0.998987,0.0002095583,0.0001637277,0.00008382442,0.00005323125,0.0005026295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8778392,0.0364435,0.001963053,0.0004078519,0.0009595838,0.0001543461,0.0001281145,0.001893378,0.0195467,0.0004154652,0.003150298,0.05709843],"study_design_scores_gemma":[0.7333479,0.2563201,0.004584499,0.00001724692,0.0003227337,0.0001684313,0.00004219584,0.0008868622,0.002462271,0.0002860985,0.001539726,0.00002200364],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919784,0.002263993,0.000451676,0.0006106137,0.0001828956,0.001274781,0.0009614481,0.00008987889,0.002186271],"genre_scores_gemma":[0.9877151,0.002026168,0.0009625006,0.0008160329,0.0002569081,0.001530446,0.002477483,0.00004274809,0.004172526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004626551,"threshold_uncertainty_score":0.0154773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02456018373456367,"score_gpt":0.3771726373027213,"score_spread":0.3526124535681577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}